TERT and Miyoshi myopathy: From the perspective of the lesion site, the majority of TERT promoter mutations occur at positions -124 and -146, with these mutations being most prevalent in cutaneous melanoma (CM), accounting for 84% of cases, compared to 15% in mucosal melanoma (MM) and 10% in acral melanoma (AM).